This review aims to briefly discuss a short list of a broad variety of inflammatory cytokines.
Numerous studies have implicated that inflammatory cytokines exert important effects with …

Osteocalcin (OC) is the most abundant non-collagenous and osteoblast-secreted protein in
bone. It consists of two forms such as carboxylated OC (cOC) and undercarboxylated OC …

We previously demonstrated the aberrant expression of nine specific miRNAs in serum from
osteoporotic patients. In the present study, we further evaluated the expression of these …

Postmenopausal osteoporosis is an important metabolic bone disease characterized by
rapid bone loss occurring in the postmenopausal period. Recently, the most prevalent form …

Purpose Hypoestrogenism triggers increased production of inflammatory mediators, which
contribute to bone loss during postmenopausal osteoporosis. This study aimed to …

Background Circulatory osteocalcin (OC) has been widely used as a biomarker to indicate
bone turnover status in postmenopausal osteoporosis (PMO). However, the change of …

Monotropein is a natural iridoid glycoside enriched in Morinda officinalis and has been used
for medicinal purposes in China. In the present study, we systematically examined its effects …

Receptor activator of the nuclear factor-κB ligand (RANKL) and osteoprotegerin genes
(OPG) were identified as susceptible loci for postmenopausal osteoporosis (PMO) in various …

Purpose The immunomodulatory properties of n-3 long chain polyunsaturated fatty acids
(LCPUFA) are reported to reduce bone loss through alteration of bone remodelling and n-3 …

Objective To assess vitamin D, parathyroid hormone, calcitonin, calcium, phosphorus and
magnesium levels in patients with versus without temporomandibular disorders (TMDs) …